A within-host drug resistance model with continuous state-dependent viral strains
From MaRDI portal
Publication:2176469
DOI10.1016/j.aml.2020.106223zbMath1437.92075OpenAlexW2999095302WikidataQ126345809 ScholiaQ126345809MaRDI QIDQ2176469
Zhipeng Qiu, Ting Guo, Libin Rong
Publication date: 4 May 2020
Published in: Applied Mathematics Letters (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.aml.2020.106223
Global stability of solutions to ordinary differential equations (34D23) Medical epidemiology (92C60)
Related Items (3)
HIV models with non‐exponential probability distributed infection progression ⋮ Dynamical analysis of a delayed HIV virus dynamic model with cell-to-cell transmission and apoptosis of bystander cells ⋮ Modeling the Effect of Reactive Oxygen Species and CTL Immune Response on HIV Dynamics
Cites Work
- Global properties of basic virus dynamics models
- An in-host model of HIV incorporating latent infection and viral mutation
- A model incorporating combined RTIs and PIs therapy during early HIV-1 infection
- Global stability of the endemic equilibrium in infinite dimension: Lyapunov functions and positive operators
- Global dynamics of an infinite dimensional epidemic model with nonlocal state structures
- Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitor
- HIV drug resistance: insights from mathematical modelling
- Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- DYNAMICAL MODEL OF IN-HOST HIV INFECTION: WITH DRUG THERAPY AND MULTI VIRAL STRAINS
- Flu epidemics: a two-strain flu model with a single vaccination
- EVALUATION OF THE TUBERCULOSIS TRANSMISSION OF DRUG-RESISTANT STRAINS IN MAINLAND CHINA
- Frobenius Theory of Positive Operators: Comparison Theorems and Applications
- Dynamical systems in population biology
This page was built for publication: A within-host drug resistance model with continuous state-dependent viral strains
